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Cannabinoid compounds may influence both emotional and cognitive processes
depending on the level of environmental aversiveness at the time of drug administration.
However, the mechanisms responsible for these responses remain to be elucidated. The
present experiments investigated the effects induced by the endocannabinoid transport
inhibitor AM404 (0.5–5mg/kg, i.p.) on both emotional and cognitive performances of rats
tested in a Spatial Open Field task and subjected to different experimental settings,
named High Arousal (HA) and Low Arousal (LA) conditions. The two different experimental
conditions influenced emotional reactivity independently of drug administration. Indeed,
vehicle-treated rats exposed to the LA condition spent more time in the center of the
arena than vehicle-treated rats exposed to theHA context. Conversely, the different arousal
conditions did not affect the cognitive performances of vehicle-treated animals such as the
capability to discriminate a spatial displacement of the objects or an object substitution.
AM404 administration did not alter locomotor activity or emotional behavior of animals
exposed to both environmental conditions. Interestingly, AM404 administration influenced
the cognitive parameters depending on the level of emotional arousal: it impaired the
capability of rats exposed to the HA condition to recognize a novel object while it did not
induce any impairing effect in rats exposed to the LA condition. These findings suggest that
drugs enhancing endocannabinoid signaling induce different effects on recognitionmemory
performance depending on the level of emotional arousal induced by the environmental
conditions.
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INTRODUCTION
The endocannabinoid system is a crucial regulator of central
nervous system (CNS) function (Cravatt et al., 1996; Di Marzo
and Matias, 2005; Pacher et al., 2006; Trezza et al., 2008b;
Campolongo et al., 2009b,c, 2011; Bisogno and Di Marzo,
2010; Hill and McEwen, 2010). Endocannabinoids are released
from post-synaptic neurons in an activity-dependent manner,
travel retrogradely through the synaptic cleft and activate pre-
synaptic cannabinoid type 1 receptors (CB1), thus suppress-
ing neurotransmitter release from axon terminals (Wilson and
Nicoll, 2002). Among the endogenous cannabimimetic signal-
ing molecules, anandamide (N-arachidonoylethanolamine, AEA)
and 2-arachidonoylglycerol (2-AG) stand out as the first iden-
tified and most intensively studied (Ueda et al., 1995, 2011; Di
Marzo, 1998; Piomelli, 2003; Waku, 2006). Receptor activation
by endocannabinoids ends by the removal from the synaptic
cleft operated by a transport system present in neural and non-
neural cells (Di Marzo et al., 1994; Beltramo et al., 1997; Hillard
et al., 1997) followed by hydrolysis operated by fatty-acid amide
hydrolase (FAAH, that hydrolyzes anandamide) or monoacyl-
glycerol lipase (MAGL, that cleaves 2-AG) (Desarnaud et al.,
1995; Hillard et al., 1995; Ueda et al., 1995; Cravatt et al.,
1996). Interestingly, while the endocannabinoid hydrolyzing
enzymes have been fully identified and cloned, the functional
properties of the putative transporter have been only partially
characterized (Hillard and Jarrahian, 2003; Yates and Barker,
2009; Fu et al., 2011) and its molecular identity remains still
unknown.
CB1 receptor is crucially involved in neural plasticity mech-
anisms related to the processing, consolidation, and extinc-
tion of emotionally salient cognitive events (Marsicano et al.,
2002; Laviolette and Grace, 2006a,b; Campolongo et al., 2009a,b;
Mackowiak et al., 2009; Abush and Akirav, 2010; Akirav, 2011;
Hauer et al., 2011). This fits well with the notion that CB1
receptors are highly expressed in brain structures including the
basolateral amygdala (BLA), the medial prefrontal cortex (mPFC)
and the hippocampus (Breivogel and Childers, 1998; Mackie,
2005; Katona, 2009), strictly associated with both cognitive and
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emotional processes (Laviolette and Grace, 2006a; Viveros et al.,
2007; McLaughlin and Gobbi, 2011; Tan et al., 2011).
Animal studies have demonstrated that the endocannabinoid
system modulates recognition memory by altering the mech-
anisms responsible for this process within the hippocampus
and selectively affecting the encoding stage (Barna et al., 2007).
Moreover, the important involvement of other structures, for
instance the amygdala, in the modulation of memory consolida-
tion and extinction for emotional events has been firmly estab-
lished (McGaugh, 2000; Vianna et al., 2004; Clarke et al., 2008;
de Oliveira Alvares et al., 2008, 2010; Campolongo et al., 2009b;
Ganon-Elazar and Akirav, 2009; Manwell et al., 2009; Roozendaal
and McGaugh, 2011). In line with the widespread distribution of
CB1 receptors throughout the limbic system, it has been exten-
sively demonstrated that cannabinoid compounds also induce
diverse effects on anxiety- and fear-related behaviors (Trezza
et al., 2008a, 2012; Micale et al., 2009; Moreira and Wotjak, 2010;
Terzian et al., 2011). Interestingly, cannabinoid effects on emo-
tionality are biphasic, as it is also reported by cannabis abusers
(Fant et al., 1998; Hall and Solowij, 1998; Bolla et al., 2002; Curran
et al., 2002). The classical explanation to this phenomenon is
often provided by the use of different doses of cannabinoid drugs,
with low doses generally inducing anxiolytic-like effects and high
doses often causing the opposite. A new and appealing explana-
tion to this phenomenon is now emerging, underlying that these
opposite effects may also depend on previous experiences, the
context of use and the level of emotional arousal at the time of
drug administration/consumption (Akirav, 2011; Sciolino et al.,
2011). Drugs that interfere with endocannabinoid degradation
increase ongoing endocannabinoid signaling in a temporarily
and spatially restricted manner (Janero et al., 2009). However,
preclinical evidence has shown that indirect cannabinoid ago-
nists can also induce biphasic effects on behavior, depending
on the emotional state of the subject. For instance, it has been
recently demonstrated that the FAAH inhibitor URB597 does
not affect anxiety under mildly stressful circumstances but has
robust anxiolytic-like effects in highly aversive testing conditions
(Haller et al., 2009). This finding leaves open the possibility that
inhibitors of endocannabinoid transport, which prolong endo-
cannabinoid actions by preventing endocannabinoid access to
intracellular hydrolyzing enzymes (Beltramo et al., 1997; Kathuria
et al., 2003), may influence both emotional and cognitive pro-
cesses depending on the level of environmental aversiveness at the
time of drug administration.
To address this issue, in the present study we investigated the
effect of the prototypical endocannabinoid transport inhibitor,
AM404 in a non-aversive task, the Spatial Open Field test under
two experimental conditions differing by the level of emotional
arousal at the time of testing. The Spatial Open Field task has
been extensively used (Poucet et al., 1986; Thinus-Blanc et al.,
1987; Poucet, 1989, 1993; Ricceri et al., 1999, 2002; Scattoni et al.,
2004; de Bartolo et al., 2010) and permits to assess both emotional
and cognitive parameters, in terms of reactivity to a spatial or an
object novelty, by exploiting the natural propensity of rodents
to explore the environment. The High Arousal condition (HA)
was obtained by testing rats in an empty arena under white light
illumination without previous handling, while the Low Arousal
condition (LA) was obtained by extensively handling the animals
before testing in an arena with the ground loaded with familiar
bedding, under a dim red lighted room.
By manipulating the experimental conditions and the tone of
endogenous cannabinoids, this study may help to explain how the
interaction between endocannabinoids and environment could
influence recognition memory in rats.
MATERIALS ANDMETHODS
ANIMALS
Male adult Wistar rats (300 g at the time of testing, Charles River
Laboratories, Italy) were housed in groups and maintained in a
temperature-controlled environment (20 ± 1◦C) under a 12 h
light/12 h dark cycle (7:00 am to 7:00 pm lights on) with unlim-
ited access to food and water. All procedures involving animal care
or treatments were approved by the ItalianMinistry of Health and
performed in compliance with the guidelines of the US National
Institutes of Health (NIH) and the Italian Ministry of Health
(D.L. 116/92), the Declaration of Helsinki, the Guide for the Care
and Use of Mammals in Neuroscience and Behavioral Research
(National Research Council 2004) and the Directive 2010/63/EU
of the European Parliament and of the Council of 22 September
2010 on the protection of animals used for scientific purposes.
DRUG TREATMENTS
N-(4-Hydroxyphenyl)-5Z,8Z,11Z,14Z-eicosatetraenamide (AM-
404, 0.5–1–5mg/kg), purchased from Tocris Bioscience (UK), was
dissolved in a vehicle containing 10% polyethylene glycol, 10%
Tween-80, and 80% saline. Drug solutions were freshly prepared
before each experiment and administered by intraperitoneal
injection in a volume of 1ml/kg 15min before the beginning of
the task.
SPATIAL OPEN FIELD PROCEDURES
The apparatus consisted in an open-field arena made of black
Plexiglas (80 × 80 × 60 cm) surrounded with a visually uniform
environment. A video camera above the field was connected to a
video recorder. Experiments were performed between 10.00 am
and 2.00 pm.
To assess the effect of the exogenous manipulation of the endo-
cannabinoid tone on short-term memory performance, the test
schedule consisted of a single task composed by six 5-min con-
secutive sessions taking place during the same day, separated by
3-min delays during which the subjects were returned to their
home cage (Figure 1). During session 1, each rat was placed into
the center of the empty arena to allow it to become familiar
with the apparatus and to record baseline levels of locomotor
and exploratory activity. Starting from session 2, three different
objects were simultaneously present in the open field: Object A, a
dark metal parallelepiped (4 cm high × 13 cm wide× 9 cm long);
Object B, a transparent Plexiglas cube with holes regularly dis-
tributed on the sides (height = 10 cm); Object C, a gray plastic
square (10 × 10 × 10 cm) with a central triangle forming a 90◦
angle. During sessions 2–3, the A, B, and C objects were placed
in the arena. In session 4, the spatial test session, the configura-
tion was changed by moving two objects: object B replaced object
A which was itself displaced at the periphery of the apparatus.
Frontiers in Behavioral Neuroscience www.frontiersin.org March 2012 | Volume 6 | Article 11 | 2
Campolongo et al. Cannabinoids, recognition memory and environmental aversiveness
In session 5, the configuration of the objects was unchanged to
let the rats habituate to the new arrangement of the objects. In
the last session (session 6) one of the familiar, non-displaced
objects (object C) was replaced by a new object (object D), which
consisted of a black-and-white plastic cylinder, height = 13 cm;
diameter = 6 cm (Figure 1).
We exposed the rats to two experimental conditions, named
HA and LA conditions. In the HA condition (Experiment 1),
the test was performed under normal light (30–40 lux), rats were
not handled and tested in an empty arena (no bedding). In the
LA condition (Experiment 2), the test was performed under dim
red light (2 lux) condition, rats were extensively habituated to the
experimenter and to the injection procedure for one week before
the experiment (every day, 1min per each rat) and tested in an
arena with the ground loaded with familiar bedding.
STATISTICAL ANALYSIS
Data collection was performed from the same observer who was
unaware of animal treatment using the Observer XT software
(Noldus, Netherland). During the first session, frequency and/or
duration of the following responses were measured: crossings,
rearings, and time spent in the center of the apparatus. From ses-
sions 2–6, object exploration was measured as total time spent by
the animal in contact with an object (1 s as minimal contact was
considered) throughout all sessions 2–6.
The total time spent by rats investigating all objects through-
out all sessions has been considered as an indicator of general
FIGURE 1 | Spatial Open-Field procedure. Schematic diagram
representing the object configuration in the Spatial Open-Field test:
(A) session 1, open field without objects; (B) session 2, habituation session
with three stable objects; (C) sessions 3–4, spatial change discrimination
sessions where object B displaced object A (session 4); (D) session 5–6,
object novelty sessions where object D replaced object C (session 6).
investigative activity. A contact was defined as the subject’s snout
actually touching an object. In session 4, the spatial arrangement
of the objects was modified and response to spatial change was
assessed by comparing the mean time spent in contact with both
Displaced (DO) and Non-Displaced (NDO) Objects in session
4 minus the mean time spent in contact with the same object
in session 3. A discrimination index of the response to the spa-
tial change was obtained by subtracting the NDO value to DO
value. Finally, the response to the non-spatial novelty was assessed
by comparing mean time in contact with the Substituted Object
(SO, unfamiliar) and Non-Substituted Objects (NSO, familiar)
in session 6 minus the mean time spent with objects located in
the corresponding position in session 5. A discrimination index
of the response to the non-spatial novelty was obtained by sub-
tracting the NSO value to SO value. Unpaired t-test was used
to compare the behavioral performance of vehicle groups. One-
sample t-tests were used to determine whether the discrimination
index was different from zero. Treatment (AM404) effects were
analyzed by One-Way analysis of variance (ANOVA) or ANOVA
for repeated measures (when appropriate), followed by Tukey’s
post-hoc comparison tests. A probability level of < 0.05 was
accepted as statistically significant.
RESULTS
DIFFERENT AROUSAL CONDITIONS INFLUENCED EMOTIONAL
BEHAVIOR AND OBJECT EXPLORATION BUT DID NOT ALTER
COGNITIVE PERFORMANCES OF VEHICLE-TREATED ANIMALS
Unpaired t-test showed that the different arousal context did not
affect locomotor activity of the vehicle groups. Both crossing
(Figure 2A) and rearing (Figure 2B) frequencies did not statis-
tically differ between the two groups (t = −0.66; p = 0.52; t =
1.09; p = 0.29, respectively). However, unpaired t-test showed
that the different arousal conditions influenced the emotional
behavior of vehicle-treated animals exposed to the different
experimental contexts. Rats treated with vehicle and exposed to
a High Arousal condition (HA group) spent less time in the cen-
ter of the arena than vehicle-treated rats exposed to a Low Arousal
context (LA group) (t = −4.11; p = 0.0005, Figure 2C).
FIGURE 2 | Effects induced by different arousal conditions on
locomotor activity and emotional behavior of vehicle-treated rats.
Locomotor activity: number of crossing (A) and rearing (B) in session 1.
Emotional behavior: time spent in the center of the arena in session 1 (C).
**P < 0.01. Data are expressed as mean ± SEM. (High Arousal: HA n = 10;
Low Arousal: LA n = 15).
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FIGURE 3 | Effects induced by different arousal conditions on object
investigation and cognitive performances of vehicle-treated rats. Total
investigation time of all objects through sessions (A) spatial change
discrimination (B) and object novelty discrimination (C).**P < 0.01. Data
are expressed as mean ± SEM. (High Arousal: HA n = 10; Low Arousal: LA
n = 15).
Unpaired t-test showed that rats treated with vehicle and
exposed to a HA context spent less time investigating objects
than vehicle-treated rats exposed to a LA context (t = −4.41;
p < 0.0001, Figure 3A). Additionally, unpaired t-test showed that
both vehicle groups did not differ in the discrimination index
for a spatial object displacement in session 4 (t = 0.60; p = 0.55,
Figure 3B) and for the substitution of the objects in session
6 (t = 0.47; p = 0.64, Figure 3C). However, One-sample t-tests
revealed that while both vehicle groups were able to discrimi-
nate the object novelty (veh-HA, t9 = 4.49, P = 0.0015; veh-LA,
t14 = 2.61, P = 0.02, Figure 3C) they did not respond to a spa-
tial rearrangement (veh-HA, t9 = 1.10, P = 0.30; veh-LA, t14 =
0.16, P = 0.88, Figure 3B).
AM404 ADMINISTRATION DID NOT ALTER LOCOMOTOR
ACTIVITY AND EMOTIONAL BEHAVIOR IN RATS EXPOSED TO
DIFFERENT AROUSAL CONDITIONS
AM404 administration did not alter locomotor activity of rats
exposed to either a HA or LA condition. One–Way ANOVA for
crossing (Figure 4A) and rearing (Figure 4B) frequencies in ses-
sion 1 for AM404-treated rats exposed to a HA condition did
not show a statistically significant difference (F3, 36 = 0.60; p =
0.62; F3, 36 = 1.44; p = 0.25, respectively). Moreover, One–Way
ANOVA for the number of crossings (Figure 4C) or rearings
(Figure 4D) in session 1 did not show a statistically significant
difference between vehicle- and AM404-treated rats exposed to
a LA condition (F3, 50 = 0.97; p = 0.42; F3, 50 = 2.21; p = 0.10,
respectively).
AM404 administration did not affect emotional reactivity in
rats exposed to either a HA or LA condition. Indeed, One-Way
ANOVA showed that vehicle- and AM404-treated rats did not
differ for the time spent in the center of the arena in session 1
(HA condition: F3, 36 = 1.25; p = 0.31; Figure 5A; LA condition:
F3, 50 = 1.18; p = 0.33; Figure 5B).
AM404 ADMINISTRATION INFLUENCED OBJECT EXPLORATION
DEPENDING ON THE DIFFERENT AROUSAL CONDITION
The time spent in contact with objects throughout sessions 2–6
was analyzed with a mixed model-ANOVA taking treatment
FIGURE 4 | Effects of AM404 administration on locomotor activity in
rats exposed to high arousal (HA) or low arousal (LA) conditions.
Number of crossing (A) and rearing (B) of rats exposed to HA or LA
conditions (C, D, respectively) in session 1. Data are expressed as mean ±
SEM. (HA: veh n = 10, 0.5mg/kg n = 11, 1mg/kg n = 10, 5mg/kg n = 9;
LA: veh n = 15, 0.5mg/kg n = 12, 1mg/kg n = 14, 5mg/kg n = 13).
FIGURE 5 | Effects of AM404 administration on emotional behavior in
rats exposed to high arousal (HA) or low arousal (LA) conditions. Time
spent in the center of the arena by rats exposed to HA (A) or LA conditions
(B) in session 1. Data are expressed as mean ± SEM. (HA: veh n = 10,
0.5mg/kg n = 11, 1mg/kg n = 10, 5mg/kg n = 9; LA: veh n = 15, 0.5mg/kg
n = 12, 1mg/kg n = 14, 5mg/kg n = 13).
as one between-subject factor and sessions as one repeated
measure factor. The mixed model-ANOVA for rats subjected
to the HA condition gave the following differences: treatment
F3, 33 = 2.72; p = 0.02; sessions F4, 132 = 39.78; p < 0.0001,
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FIGURE 6 | Effects of AM404 administration on object investigation in
rats exposed to high arousal (HA) or low arousal (LA) conditions. Total
investigation time of all objects by rats exposed to HA (A) or LA (B)
conditions through sessions 2–6. *P < 0.05. Data are expressed as mean
± SEM. (HA: veh n = 10, 0.5mg/kg n = 11, 1mg/kg n = 10, 5mg/kg n = 9;
LA: veh n = 15, 0.5mg/kg n = 12, 1mg/kg n = 14, 5mg/kg n = 13).
interaction treatment × sessions F12, 132 = 1.50; p = 0.13. Since
the interaction between treatment and sessions was not statisti-
cally significant, for a clearer representation of the results, data are
represented in Figure 6 as themean time spent in contact with the
objects during all sessions. Individual comparisons (Tukey’s test)
performed on the main effect of treatment, revealed that AM404
(0.5mg/kg) treated rats spent less time exploring the objects than
control animals (p < 0.05, Figure 6A).
On the other hand, the mixed model-ANOVA for rats sub-
jected to the LA condition revealed only a statistical signifi-
cant effect for sessions without any statistical significance for
either treatment or interaction between treatment and sessions:
treatment F3, 46 = 0.12; p = 0.95; sessions F4, 184 = 20.82; p <
0.0001, interaction treatment× sessions F12, 132 = 1.20; p = 0.29
(Figure 6B), indicating that AM404 administration did not influ-
ence the total object investigation time in rats subjected to the LA
arousal condition.
AM404 ADMINISTRATION DID NOT INFLUENCE SPATIAL CHANGE
DISCRIMINATION WHILE IT ALTERED OBJECT NOVELTY RECOGNITION
IN RATS EXPOSED TO DIFFERENT AROUSAL CONDITIONS
One–Way ANOVA showed that administration of AM404 did
not influence the rat capability to discriminate the object dis-
placement under both the HA (Figure 7A) or LA (Figure 7B)
experimental conditions (F3, 36 = 1.176; p = 0.34; F3, 50 = 2.24;
p = 0.095, respectively). However, One–Way ANOVA showed a
statistical significant effect on the capability of the rats to discrim-
inate a novel object under a HA condition (F3, 36 = 4.32; p =
0.01; Figure 8A). Post-hoc comparisons revealed that rats admin-
istered with AM404 0.5 and 1mg/kg were not able to discriminate
the new object as vehicle-treated rats did (p < 0.05). One–Way
ANOVA revealed that AM404 administration to LA exposed rats
did not influence the capability of the rats to discriminate the new
object compared to the vehicle group (F3, 50 = 0.26; p = 0.85;
Figure 8B).
DISCUSSION
The present findings demonstrate that: (1) different levels of
environmental aversiveness strongly influence the emotional
FIGURE 7 | Effects of AM404 administration on spatial change
discrimination in rats exposed to high arousal (HA) or low arousal (LA)
conditions. Spatial change discrimination index of rats exposed to HA (A)
or LA (B) conditions. Tim spent in contact with Displaced (DO) and
Non-Displaced (NDO) Objects in session 4 minus the mean time spent in
contact with the same object in session 3. A discrimination index was
obtained by subtracting the NDO value to DO value. Data are expressed as
mean ± SEM. (HA: veh n = 10, 0.5mg/kg n = 11, 1mg/kg n = 10, 5mg/kg
n = 9; LA: veh n = 15, 0.5mg/kg n = 12, 1mg/kg n = 14, 5mg/kg n = 13).
FIGURE 8 | Effects of AM404 administration on object novelty
discrimination in rats exposed to high arousal (HA) or low arousal (LA)
conditions. Object novelty discrimination index of rats exposed to HA (A)
or LA (B) conditions. Time spent in contact with Substituted Object (SO,
unfamiliar) and Non-Substituted Objects (NSO, familiar) in session 6 minus
the mean time spent with objects located in the corresponding position in
session 5. A discrimination index was obtained by subtracting the NSO
value to SO value. *P < 0.05. Data are expressed as mean ± SEM. (HA:
veh n = 10, 0.5mg/kg n = 11, 1mg/kg n = 10, 5mg/kg n = 9; LA: veh
n = 15, 0.5mg/kg n = 12, 1mg/kg n = 14, 5mg/kg n = 13).
reactivity of untreated rats without affecting the cognitive per-
formance in the Spatial Open-Field test; (2) endocannabinoids
affect recognition memory of rats in the Spatial Open Field test
depending on the level of emotional arousal induced by the
environmental conditions.
The Spatial Open-Field is a non-aversive test that permits
to assess several behaviors which are indicative of the emo-
tional state of the animal as well as the reactivity to both spatial
rearrangement (spatial novelty) or the replacement of one famil-
iar object with a new one (object novelty, as in the classical
object recognition task) (Poucet et al., 1986; Thinus-Blanc et al.,
1996). This test exploits the natural propensity of rodents to
explore the environment without using rewards or punishments.
Previous studies have shown that naive rodents respond to a
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new spatial displacement or substitution by renewed exploration
of the entire environment and/or by selective reinvestigation of
the displaced/substituted objects (Poucet et al., 1986; Thinus-
Blanc et al., 1987; Poucet, 1989, 1993; Ricceri et al., 1999, 2000,
2002; Scattoni et al., 2004; de Bartolo et al., 2010). The one-day
six-session assessment of the task used in our study permits to
determine pharmacological effects on short-term memory as well
as on emotional reactivity of the subject.
Activation of emotional responses, triggered by stressful stim-
uli, is crucial in the modulation of contextual learning and mem-
ory performances (McGaugh and Roozendaal, 2002; McGaugh,
2004; Morris, 2006; Campolongo et al., 2009b; Hill et al., 2010).
There is evidence that behavioral responses to the environmental
stimuli are strictly dependent on the emotional reactivity induced
by the environment itself (Blanchard et al., 2001; Haller et al.,
2009). The environmental–induced arousal is critically involved
in assessing the novelty and salience of the external stimuli in
terms of relevance for the adaptation and survival (Poucet, 1993;
Biegler and Morris, 1996; Breivogel and Childers, 1998). Thus,
when compared with a previous experience, a novel information
recognized as highly relevant is committed to and stored by the
memory (Lemaire et al., 1999). However, the mechanisms under-
lying themodulation of responsiveness to the environment and its
evaluation in evolutionary terms both under LA or HA contexts
remain to be elucidated.
Based on previous findings (Szeligo and Leblond, 1977;
Sahakian et al., 1982; Morato and Castrechini, 1989; Griebel
et al., 1993; Escorihuela et al., 1994; Hall et al., 1998; Varty
et al., 2000; Haller et al., 2009), in order to characterize the
behavioral responses to different environmental situations, we
manipulated the experimental context to create two opposite
arousal conditions by using two different protocols: (1) rats either
extensively handled or not handled by the experimenter before
testing, (2) isolated- or grouped-housed rats; (3) bright or dim
red light conditions; (4) without or with familiar bedding dur-
ing the testing phase for HA or LA conditions, respectively (for a
comprehensive description see Materials and Methods). By using
these different experimental conditions, we were able to induce
a high or a low state in the animal, independently of any drug
administration.
To first characterize the behavioral responses of rats to dif-
ferent environmental situations in the Spatial Open Field task,
regardless of any drug administration, we analyzed the perfor-
mance of vehicle-treated rats exposed to a HA or a LA context.
The analysis of the first session of the Spatial Open Field task
(when no objects were present) showed that locomotor activity
was not influenced by the two different arousal conditions, while
the different environmental situations influenced the level of
emotional reactivity of the animals. Vehicle-treated rats, exposed
to the LA context, spent indeed more time in the center of the
open field than vehicle-treated rats exposed to the HA context.
This result indicates that the LA environment may induce a lower
level of emotional activation (Prut and Belzung, 2003).
The view that LA condition induces a lower level of emotional
activation is also supported by behavioral analysis derived from
sessions 2 to 6 of the task, in which the rats encountered differ-
ent objects, also located in different positions in the open-field
arena. Rats exposed to the LA context spent more time investigat-
ing the objects than rats exposed to the HA context, suggesting
that a lower state of anxiety urges animals to better explore the
objects (Crawley, 1985). Concerning the cognitive performance,
the different level of emotional activation derived by exposure to
the two environmental conditions did not influence the cogni-
tive parameters measured in the task. Indeed, vehicle-treated rats
exposed to either HA or LA conditions were equally able to rec-
ognize the object substitution but failed to respond to the object
displacement. Interestingly, Ricceri and co-workers (Ricceri et al.,
2000) showed that only 90-day-old mice were able to discrimi-
nate a spatial object rearrangement, while 46-day-old mice were
not. In our study, we used young adult rats; this leaves open the
possibility that the ability to discriminate a spatial change has
to be still developed by rats at this age. Moreover, our findings
are in accordance with the general assumption that the capabil-
ity to recognize a new setting of the environment is important
for the species survival, but the impact of the object novelty is
more salient than a spatial rearrangement with the same objects
(Mumby et al., 2002).
Extensive evidence demonstrates that the endocannabinoid
system is a crucial regulator of emotionality and cogni-
tion (Marsicano et al., 2002; Laviolette and Grace, 2006a,b;
Campolongo et al., 2009a,b; Mackowiak et al., 2009; Abush
and Akirav, 2010; Akirav, 2011; Trezza et al., 2012). Although
the neurobiological mechanisms underlying cannabinoid manip-
ulation of emotional and cognitive functions have not yet
been completely elucidated, previous evidence demonstrates that
the anxiolytic effects induced by pharmacological enhancement
of endocannabinoid tone strongly depend on the emotional
state at the time of testing (Patel and Hillard, 2006) and that
these effects are modulated by the level of emotional reactiv-
ity induced by high or low aversive experimental conditions
(Haller et al., 2009).
To further shed light on the role of environmental aversive-
ness in cannabinoid modulation of emotionality and cognitive
performance, we investigated whether exogenous manipulation
of the endocannabinoid system influences rat behavior in the
Spatial Open Field task in experimental conditions character-
ized by either a HA or LA state. Our findings clearly show that
the effects of the endocannabinoid transport inhibitor AM404
on cognitive responses in the Spatial Open Field test strongly
depend on the level of emotionality at the time of testing. Indeed,
AM404 administration impaired the rat capability to discriminate
between a familiar and a new object only in rats exposed to the
HA condition.
Several studies have shown that CB1 receptor agonists pro-
duce anxiolytic- (Patel and Hillard, 2006; Scherma et al., 2008)
or anxiogenic-like (Viveros et al., 2005; Patel and Hillard,
2006) effects, depending on the dose tested. Conversely, indirect
cannabinoid agonists, that increase ongoing endocannabinoid
signaling by interfering with their deactivation, induce anxiolytic-
like effects without anxiogenic responses also when administered
at high doses. For instance, the FAAH inhibitor URB597 pro-
duces anxiolytic-like effects in the elevated zero-maze and in
the ultrasonic vocalization test in rats (Kathuria et al., 2003).
In accordance with these findings, FAAH knockout mice exhibit
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an anxiolytic-like phenotype in the elevated plus-maze and in
the light-dark box tests (Naidu et al., 2007; Moreira et al.,
2008, 2009). Anxiolytic-like effects can also be induced by the
inhibition of the endocannabinoid transport operated by endo-
cannabinoid uptake inhibitors like AM404 (Beltramo et al., 1997;
Beltramo and Piomelli, 2000). Thus, it has been demonstrated
that the systemic administration of AM404 produces anxiolytic-
like effects in three rat models of anxiety: elevated plus maze,
defensive withdrawal, and separation-induced ultrasonic vocal-
ization tests, and these effects are blocked by the administration
of the CB antagonist rimonabant (Bortolato et al., 2006; Patel and
Hillard, 2006). Nevertheless, it should be noted that in an another
study Moreira and co-workers (Moreira et al., 2007) found that
co-administration of anandamide and AM404 in the rat peri-
aqueductal gray (a brain structure related to aversive response)
elicited anxiolytic-like responses in the elevated plus maze test,
whereas AM404 alone did not. In the present study, we found
that administration of AM404 did not influence the emotional
parameters taken onto consideration in the Spatial Open Field
test, like the time spent in the central part of the arena dur-
ing the first session of the task. However, it is important to
note that, while AM404 administration did not influence the
investigation of the objects through session 2–6 in a context char-
acterized by a low-level of emotional activation, rats treated with
the lower dose of AM404 and exposed to a stressful environ-
ment spent less time investigating objects, whereas the higher
doses re-established the investigation activity at similar level of
the vehicle-treated rats. The inhibition or the maintenance of
the investigative behavior can be related to an anxiogenic or an
anxiolytic phenotype, respectively (Crawley, 1985). It is possible
to speculate that this biphasic effect may depend on a differ-
ential regulation activity on both GABAergic and gutamatergic
neurons mediated by different doses of the endocannabinoid
transport inhibitor (Foldy et al., 2007; Hashimotodani et al.,
2007).
Regarding the cognitive performance, here we show for the
first time that a pharmacologically-induced enhancement of
endocannabinoid tone differentially modulates memory recogni-
tion in rats depending on different emotional states and different
nature of the considered cognitive parameters (e.g., either spatial
or novel object discrimination).
Concerning the object displacement, although the results did
not reach any statistical significance it could be important to note
that the treatment effect profile resemble a trend of a typical
U-shaped dose response curve, in accordance with other results
showing a similar dose-dependent biphasic response induced by
cannabinoids, particularly by anandamide (Sulcova et al., 1998)
and by the psychoactive constituent of Cannabis sativa prepara-
tion 9-tetrahydrocannabinol (Onaivi et al., 1990; Valjent et al.,
2001). Concerning the object substitution, the lower doses of
AM404 disrupted the ability to recognize a novel object in a stress-
ful condition (HA) but not in a low arousal context (LA). It is
well-established that the capability to recognize a new setting of
the environment is important for species survival, but also that
the impact of the object novelty is more salient than a spatial rear-
rangement with the same objects (Mumby et al., 2002). However,
the capability to discriminate a novel object in the arena can be
lost under particular circumstances such as in a more stressful
context, after repeated exposure to an aversive environment and
experimental manipulation of the endocannabinoid tone as in the
present study (Save et al., 1992; Mumby et al., 2002; Hebda-Bauer
et al., 2010).
These data confirm previous findings showing similar effects
in humans and laboratory animals where acute or chronic
exposure to the psychoactive constituent of cannabis, 9-
tetrahydrocannabinol, induces impairment in cognitive function
(Egerton et al., 2006; Ranganathan and D’Souza, 2006; Solowij
and Battisti, 2008; Campolongo et al., 2009c, 2011; D’Souza et al.,
2009; Sofuoglu et al., 2010). In rodents, cannabinoid direct ago-
nists induce impairment in several cognitive performances such
as spatial learning, working memory, and attentional processes
(Presburger and Robinson, 1999; Hampson and Deadwyler, 2000;
Verrico et al., 2004; Robinson et al., 2007; Boucher et al., 2009,
2011). It is possible to speculate that these effects derive from
cannabinoid-mediated disruption of cortical and hippocampal
activity, crucially involved in encoding of the stimulus and mak-
ing cognitive associations (Robbe et al., 2006; Deadwyler et al.,
2007; Robbe and Buzsaki, 2009). The present results confirm
the hypothesis that cannabinoid drugs, depending on the dose
tested and the emotional state of the subject, could induce dif-
ferent effects on short-term memory parameters. The dissimilar
effects induced by exposure to a different emotional state could
depend on the activation of the hypothalamic-pituitary-adrenal
(HPA) axis triggered by a HA context and to the subsequent
release of stress hormones, such as glucocorticoids. It is well-
known that this axis plays a crucial role in the stress response
and that these hormones differentially modulate cognitive func-
tions (Roozendaal and McGaugh, 1997; Mizoguchi et al., 2004;
Atsak et al., 2011). In particular, de Quervain and co-workers
(2009) reported that elevated glucocorticoid levels, elicited by
aversive contexts, impair memory retrieval, and working mem-
ory. Moreover, further studies, conducted by our group, shed light
on the crucial role of endocannabinoid signaling in the baso-
lateral complex of the amygdala in modulating consolidation of
aversive memory by an interaction with the glucocorticoid sys-
tem (Campolongo et al., 2009a,b; Hill et al., 2010; Atsak et al.,
2011).
Taken together, the present findings support the hypothe-
sis of a fundamental role of the environment in influencing
both the behavioral and cognitive outcomes in the Spatial Open
Field task. Most importantly, it emerges that drugs that enhance
endocannabinoid signaling by interfering with endocannabinoid
deactivation induce different effects on short-term memory per-
formance depending on the level of emotional arousal induced by
different environmental settings.
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